EN HU

Tarapcsák Szabolcs

Tarapcsák Szabolcs

Publication list

2022
1.
Black, G. S., Huang, X., Qiao, Y., Tarapcsák, S., Rogers, K. A., Misra, S., Byrd, J. C., Marth, G., Stephens, D. M., Woyach, J. A.: Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib and acalabrutinib treated patients.
Blood. 140 (4), 401-405, 2022.
Journal metrics:
D1 Biochemistry
D1 Cell Biology
D1 Hematology
D1 Immunology
2021
2.
Singh, K., Tarapcsák, S., Gyöngy, Z., Ritter, Z., Batta, G., Bosire, R., Gálné Remenyik, J., Goda, K.: Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity.
Pharmaceutics. 13 (12), 1-17, 2021.
Journal metrics:
Q1 Pharmaceutical Science
3.
Batta, G., Kárpáti, L., Henrique, G. F., Tóth, G., Tarapcsák, S., Kovács, T., Zákány, F., Mándity, I. M., Nagy, P.: Statin-boosted cellular uptake and endosomal escape of penetratin due to reduced membrane dipole potential.
Br. J. Pharmacol. 178 (18), 3667-3681, 2021.
Journal metrics:
D1 Pharmacology
2020
4.
Goda, K., Dönmez-Cakil, Y., Tarapcsák, S., Szalóki, G., Szöllősi, D., Parveen, Z., Türk, D., Szakács, G., Chiba, P., Stockner, T.: Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.
PLoS Genet. 16 (10), 1-21, 2020.
Journal metrics:
D1 Cancer Research
D1 Ecology, Evolution, Behavior and Systematics
D1 Genetics
D1 Genetics (clinical)
D1 Molecular Biology
5.
Firouzi Niaki, E., Van Acker, T., Imre, L., Nánási, P. P. i., Tarapcsák, S., Bacsó, Z., Vanhaecke, F., Szabó, G.: Interactions of Cisplatin and Daunorubicin at the Chromatin Level.
Sci. Rep. 10 (1), 1-12, 2020.
Journal metrics:
D1 Multidisciplinary
6.
Ireland, A. S., Micinski, A. M., Kastner, D. W., Guo, B., Wait, S. J., Spainhower, K. B., Conley, C. C., Chen, O. S., Guthrie, M. R., Soltero, D., Qiao, Y., Huang, X., Tarapcsák, S., Devarakonda, S., Chalishazar, M. D., Gertz, J., Moser, J. C., Marth, G., Puri, S., Witt, B. L., Spike, B. T., Oliver, T. G.: MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
Cancer Cell. 38 (1), 60-78; e1-e12, 2020.
Journal metrics:
D1 Cancer Research
D1 Cell Biology
D1 Oncology
7.
Kiss, A., Ráduly, A. P., Regdon, Z., Polgár, Z., Tarapcsák, S., Sturniolo, I., El-Hamoly, T., Virág, L., Hegedűs, C.: Targeting nuclear NAD+ synthesis inhibits DNA repair, impairs metabolic adaptation increases chemosensitivity of U-2OS osteosarcoma cells.
Cancers (Basel). 12 (5), 1-27, 2020.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
2019
8.
Biró, A., Markovics, A., Homoki, J., Szőllősi, E., Hegedűs, C., Tarapcsák, S., Lukács, J., Stündl, L., Gálné Remenyik, J.: Anthocyanin-Rich Sour Cherry Extract Attenuates the Lipopolysaccharide-Induced Endothelial Inflammatory Response.
Molecules. 24 (19), 3427-3441, 2019.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2017
9.
Tarapcsák, S., Szalóki, G., Telbisz, Á., Gyöngy, Z., Matúz, K., Csősz, É., Nagy, P., Holb, I., Rühl, R., Nagy, L., Szabó, G., Goda, K.: Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein.
Sci Rep. 7 (41376), 1-31, 2017.
Journal metrics:
D1 Multidisciplinary
2016
10.
Bársony, O., Szalóki, G., Türk, D., Tarapcsák, S., Gutay-Tóth, Z., Bacsó, Z., Holb, I., Székvölgyi, L., Szabó, G., Csanády, L., Szakács, G., Goda, K.: A single active catalytic site is sufficient to promote transport in P-glycoprotein.
Sci. Rep. 6 (24810), 1-16, 2016.
Journal metrics:
D1 Multidisciplinary
11.
Kerényi, F., Tarapcsák, S., Hrubi, E., Baráthné Szabó, Á., Hegedűs, V., Balogh, S., Bágyi, K., Varga, G., Hegedűs, C.: Fogbél eredetű őssejtek fluoreszcens és mágneses válogatásának összehasonlító vizsgálata.
Fogorv. Szle. 109 (1), 29-33, 2016.
Journal metrics:
Q4 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen